Divalproex Sodium Extended-Release Tablets USP 250 mg: Indications, Dosage, Precautions, Adverse Effects
Россия
  • Россия
  • Украина

Manufacture: Dr. Reddy's Laboratories, Inc.
Country: India
Condition: Bipolar Disorder, Epilepsy, Mania, Migraine Prevention (Migraine Prophylaxis)
Class: Anticonvulsants, Fatty acid derivative anticonvulsants
Form: Tablets
Ingredients: divalproex sodium, hydroxy ethyl cellulose, hypromellose, lactose monohydrate, microcrystalline cellulose, polyethylene glycol, silicon dioxide, and titanium dioxide